Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Eli Lilly director Ralph Alvarez acquired 13 shares of common stock through a deferral plan, increasing his direct holdings to 54,254 shares.

Summary

• Ralph Alvarez, a director at Eli Lilly & Co, acquired 13 shares of common stock on September 16, 2024.
• The shares were acquired at a price of $923.54 per share.
• This transaction was part of the Lilly Directors' Deferral Plan, where the shares are deferred in lieu of cash compensation.
• The shares will be settled in common stock after Mr. Alvarez's separation from service.
• Following this transaction, Mr. Alvarez directly owns 54,254 shares of Eli Lilly common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally neutral. However, insider buying can be seen as a positive sign, hence a slightly positive score.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It reflects the compensation structure for directors at Eli Lilly.

Comparison to Industry Standards

• Director share acquisitions through deferral plans are a common practice among large publicly traded companies, including pharmaceutical companies like Pfizer (PFE) and Johnson & Johnson (JNJ).
• These plans are often used as part of executive compensation packages to align the interests of directors with those of shareholders.
• The specific terms of deferral and settlement may vary between companies, but the general principle of deferred stock compensation is widely adopted.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.

Key Dates

Keywords

Eli Lilly, LLY, Director, Share Acquisition, Deferral Plan, Stock Ownership, Form 4, Insider Trading